Ernexa Therapeutics (ERNA) executive compensation, 2026 proxy

Sanjeev Luther, President and Chief Executive Officer, was paid $888,813 in 2025, down 71% from $3.1M the year before.

Filed
May 11, 2026
Annual meeting
July 1, 2026
Pay year
2025
Named executives
2
CEO total pay
$888,813-71% vs prior year
CEO 2026 salary
$670,000Increased from $550,000
CEO 2026 bonus
$319,000Approved in March 2026
Gurrola 2026 salary
$300,000Increased from $275,000
Gurrola 2026 bonus
$68,000Approved in March 2026
Luther option grant
2,995 sharesGranted February 2025
Gurrola option grant
400 sharesGranted February 2025

How Luther was paid

$888,813 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary62%Option awards37%All other compensation2%

Named executive officers

ExecutiveTotal
Sanjeev LutherPresident and Chief Executive Officer$888,813
Sandra GurrolaSr. Vice President of Finance$329,372

What changed and why

  • $889K$888,813 was CEO Sanjeev Luther’s 2025 total compensation, down from $3,061,818 in 2024.
  • $325K$324,813 of Luther’s 2025 compensation came from option awards; he received no bonus or non-equity incentive compensation.
  • $43,372$43,372 was Sandra Gurrola’s 2025 option-award compensation, and her total compensation was $329,372.
  • $670K$670,000 became Luther’s annual base salary in March 2026, up from $550,000.
  • $319K$319,000 and $68,000 discretionary bonuses were approved for Luther and Gurrola, respectively, for 2025 performance.
  • 2,995 and 400 stock options were granted to Luther and Gurrola, respectively, in February 2025.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.